Home » Stocks » ELTP

Elite Pharmaceuticals, Inc. (ELTP)

Stock Price: $0.0549 USD 0.0050 (9.80%)
Updated Jan 15, 2021 3:40 PM EST - Market closed
Market Cap 55.00M
Revenue (ttm) 24.94M
Net Income (ttm) 2.63M
Shares Out 913.54M
EPS (ttm) 0.00
PE Ratio 18.30
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.0549
Previous Close $0.0500
Change ($) 0.0050
Change (%) 9.80%
Day's Open 0.0549
Day's Range 0.0520 - 0.0550
Day's Volume 1,117,805
52-Week Range 0.05 - 0.11

News

There are no news available yet.

About ELTP

Elite Pharmaceuticals engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pain... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jul 23, 1998
CEO
Nasrat Hakim
Employees
43
Stock Exchange
OTCMKTS
Ticker Symbol
ELTP
Full Company Profile

Financial Performance

In 2019, ELTP's revenue was $17.99 million, an increase of 137.76% compared to the previous year's $7.57 million. Losses were -$2.24 million, -75.86% less than in 2018.

Financial Statements